AgeX Therapeutics, Inc.·4

Nov 21, 9:07 PM ET

SEGALL JUDITH 4

4 · AgeX Therapeutics, Inc. · Filed Nov 21, 2019

Insider Transaction Report

Form 4
Period: 2019-11-19
SEGALL JUDITH
Corporate Secretary
Transactions
  • Award

    Option to Purchase Coomon Stock

    2019-11-19+15,00015,000 total
    Exercise: $1.44From: 2019-11-19Exp: 2029-11-18Common Stock (15,000 underlying)
  • Award

    Option to Purchase Coomon Stock

    2019-11-19+15,00015,000 total
    Exercise: $1.44Exp: 2029-11-18Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]One third shall vest on November 19, 2020 and the remaining shall vest in 24 equal monthly installments thereafter, based upon continuous service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION